Dv. Jeste et al., RELATIONSHIP OF ETHNICITY AND GENDER TO SCHIZOPHRENIA AND PHARMACOLOGY OF NEUROLEPTICS, Psychopharmacology bulletin, 32(2), 1996, pp. 243-251
There is considerable heterogeneity in the psychopathology of schizoph
renia and the response to neuroleptic treatment, at least some of whic
h may result from ethnicity and gender differences among subjects. We
review the literature relevant to ethnic and gender differences in psy
chopathology and neuroleptic response in schizophrenia. Studies reveal
several diagnosis- and treatment-related differences in schizophrenia
among different ethnic and gender groups. Some of these differences m
ight be biological in origin, others due to cultural or environmental
factors. In studies conducted in our center, we found no differences i
n psychopathology or amount of neuroleptic therapy between African-Ame
rican and Caucasian patients. We did note that African-American patien
ts in our sample had a somewhat greater risk of developing tardive dys
kinesia than their Caucasian counterparts. The incidence of tardive dy
skinesia was similar for males and females. Our studies of neuroleptic
-induced tardive dyskinesia were restricted to patients over age 45, t
hough there were no ethnic or gender differences in the daily neurolep
tic dose. Future work in this area should carefully compare ethnic and
gender differences in treatment response.